VIASYS Healthcare Inc. Announces the Acquisition of Intermed Precision

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Nov. 3, 2005--VIASYS Healthcare Inc. (NYSE:VAS - News; "VIASYS") announced today that it has acquired Intermed Precision, located in Gort, County Galway within the Republic of Ireland. The specific terms of the transaction were not disclosed.

Randy Thurman, Chairman, President and Chief Executive Officer, VIASYS Healthcare Inc., commented, "We believe VIASYS Orthopedics is realizing substantial success as we benefit from and take advantage of the overall positive dynamics in the orthopedics industry. The acquisition of Intermed Precision is consistent with our strategy to acquire companies in our industry to broaden our orthopedics product portfolio. With the acquisition of Intermed Precision, we will now develop and manufacture reconstructive orthopedic implants, spinal implants, trauma products, as well as related orthopedic surgical instruments. We expect that VIASYS and Intermed Precision customers will benefit from our acquisition strategy, this broader capability, and our international presence. Together, VIASYS and Intermed Precision expect to continue to increase our overall share of the outsourced orthopedics market by realizing the benefits of the combined companies and continuing to execute on our strategies."

Intermed Precision is an ISO 13488 registered developer and supplier of orthopedic instruments, implants, and micro-machined components used in minimally invasive surgical devices. The company offers a comprehensive range of services, including design, prototyping, regulatory assistance, precision machining of metals and plastics, surface treatments, and assembly. Its skilled workforce, modern equipment, and efficient manufacturing operations enable it to provide solutions to its global customers with a high level of quality and service. VIASYS believes that Intermed Precision has become recognized by several leading orthopedic original equipment manufacturers (OEMs) as a global preferred supplier, supplying to these OEMs throughout Europe and the United States.

"We believe that the addition of Intermed Precision represents a significant step in our ability to provide our orthopedic customers with a complete range of products and solutions," said Giulio Perillo, Group President of VIASYS Orthopedics. "We expect that the combination of Tecomet Inc. and Intermed Precision will offer our customers increased manufacturing capacity, allowing VIASYS Orthopedics to offer a comprehensive portfolio of development and manufacturing solutions to the orthopedics market."

ABOUT VIASYS HEALTHCARE INC.
VIASYS Healthcare Inc. is a global, research-based medical technology company focused on respiratory, neurology, medical disposable and orthopedic products. VIASYS products are marketed under well-recognized trademarks including among others AVEA®, BEAR®, BIRD®, CORFLO®, CORPAK®, EME®, GRASON-STADLER®, JAEGER(TM), LYRA®, MEDELEC®, MICROGAS®, NICOLET®, NicoletOne(TM), PULMONETIC(TM), SENSORMEDICS®, TECA®, TECOMET(TM), VELA® and VMAX®. VIASYS is headquartered in Conshohocken, PA, and its businesses are conducted through its Respiratory Care, NeuroCare, MedSystems and Orthopedics business units. More information can be found at http://www.viasyshealthcare.com.

This news release includes forward-looking statements within the meaning of the "Safe Harbor" provisions of Private Securities Litigation Reform Act of 1995 regarding the effect that the acquisition of Intermed Precision will have on the ability of VIASYS Orthopedics to offer a complete range of products and solutions and increased manufacturing capacity; the product offerings of the combined company; the benefit of the combination of the two companies to customers; and the growth of the leadership position of VIASYS Orthopedics in the orthopedics suppliers market. These forward-looking statements are based on current expectations and involve inherent risks and uncertainties, including important factors that could delay, divert, or change these expectations and could cause actual outcomes and results to differ materially from current expectations. These factors include, among other things, market factors, internal research and development initiatives, partnered research and development initiatives, competitive product and service development, marketing initiatives, governmental regulations and legislation, patent positions and patent litigation, other litigation, a successful mergers and acquisitions strategy, successful product and service development, customer acceptance of both the combined company and the products and services it offers now and will offer in the future, successful integration of Intermed into the VIASYS Orthopedics business unit, the extent to which the skills of the employees of Intermed are complementary to those of the existing VIASYS Orthopedics, continuation of the growth of the orthopedic suppliers market, and the growth of the OEM market. For further details and a discussion other risks and uncertainties that may change VIASYS' expectations, please see VIASYS' annual report on Form 10-K for the year ended January 1, 2005, which is on file with the Securities and Exchange Commission. VIASYS undertakes no obligation to publicly update this forward-looking statement, whether as a result of new information, future events, or otherwise.

Contact:
VIASYS Healthcare Inc.
Media Contact:
Giulio A. Perillo, 978-642-2408
giulio.perillo@viasyshc.com
or
Inverstor Contact:
Martin P. Galvan, 610-862-0800
marty.galvan@viasyshc.com